SFM
Sphera Funds Management Portfolio holdings
AUM
$382M
This Quarter Return
+6.19%
1 Year Return
+0.41%
3 Year Return
+99.29%
5 Year Return
+177.09%
10 Year Return
+575.73%
AUM
$1.1B
AUM Growth
+$1.1B
(+1.3%)
Cap. Flow
-$40.5M
Cap. Flow
% of AUM
-3.68%
Top 10 Holdings %
Top 10 Hldgs %
41.41%
Holding
202
New
34
Increased
34
Reduced
31
Closed
71
Top Buys
| 1 |
Xenon Pharmaceuticals
XENE
|
$51.4M |
| 2 |
Werewolf Therapeutics
HOWL
|
$12M |
| 3 |
AstraZeneca
AZN
|
$11.2M |
| 4 |
Twilio
TWLO
|
$10.4M |
| 5 |
Iovance Biotherapeutics
IOVA
|
$9.85M |
Top Sells
| 1 |
Eli Lilly
LLY
|
$56.8M |
| 2 |
AbbVie
ABBV
|
$26.3M |
| 3 |
CERE
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
|
$23.1M |
| 4 |
Bristol-Myers Squibb
BMY
|
$12.6M |
| 5 |
Palo Alto Networks
PANW
|
$10.4M |
Sector Composition
| 1 | Healthcare | 74.4% |
| 2 | Technology | 11.35% |
| 3 | Industrials | 6.46% |
| 4 | Financials | 2.77% |
| 5 | Consumer Discretionary | 2.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
AstraZeneca
AZN
$248B
| $68.7M | 4.65% | 1,147,673 +187,200 | +19% | +$11.2M |
|
2
Johnson & Johnson
JNJ
$427B
| $66.8M | 4.52% | 405,608 -48,292 | -11% | -$7.96M |
|
3
Merck
MRK
$210B
| $60.1M | 4.06% | 772,601 -36,207 | -4% | -$2.82M |
|
|
4
Xenon Pharmaceuticals
XENE
$2.98B
| $51.4M | 3.48% | +276,130 | New | +$51.4M |
|
5
Sanofi
SNY
$121B
| $44.4M | 3% | 843,400 -154,500 | -15% | -$8.14M |
|
6
Generac Holdings
GNRC
$10.9B
| $43.3M | 2.93% | 104,363 -1,300 | -1% | -$540K |
|
|
7
Eli Lilly
LLY
$657B
| $41.7M | 2.82% | 181,895 -247,305 | -58% | -$56.8M |
|
|
8
AbbVie
ABBV
$372B
| $41.2M | 2.79% | 366,194 -233,306 | -39% | -$26.3M |
|
9
C4 Therapeutics
CCCC
$185M
| $19.6M | 1.33% | 518,611 +21,475 | +4% | +$813K |
|
10
Nice
NICE
$8.73B
| $19M | 1.29% | 76,786 +37,305 | +94% | +$9.23M |
|
11
ESSA Pharma
EPIX
$11.4M
| $18.5M | 1.25% | 648,303 +179,062 | +38% | +$5.12M |
|
12
Kornit Digital
KRNT
$669M
| $18.4M | 1.24% | 147,793 -588 | -0.4% | -$73.1K |
|
13
Microsoft
MSFT
$3.77T
| $18.3M | 1.24% | 67,536 | – | – |
|
14
Kura Oncology
KURA
$686M
| $18.1M | 1.23% | 868,886 +151,135 | +21% | +$3.15M |
|
15
Zai Lab
ZLAB
$3.68B
| $17.3M | 1.17% | 97,946 +32,158 | +49% | +$5.69M |
|
|
SWTX
16
DELISTED
SpringWorks Therapeutics
SWTX
| $16.1M | 1.09% | 195,117 +57,445 | +42% | +$4.73M |
|
17
Fate Therapeutics
FATE
$120M
| $14.3M | 0.97% | 165,299 +55,492 | +51% | +$4.82M |
|
18
LivePerson
LPSN
$90.1M
| $14.2M | 0.96% | 225,000 -35,000 | -13% | -$2.21M |
|
19
Amazon
AMZN
$2.44T
| $14M | 0.94% | 4,061 +1,300 | +47% | +$4.47M |
|
20
Protagonist Therapeutics
PTGX
$3.67B
| $13.6M | 0.92% | 302,965 +100,831 | +50% | +$4.53M |
|
21
VistaGen Therapeutics
VTGN
$102M
| $12.9M | 0.87% | 4,080,673 -96,485 | -2% | -$304K |
|
22
AudioCodes
AUDC
$273M
| $12.7M | 0.86% | 385,194 -90,430 | -19% | -$2.99M |
|
23
Kymera Therapeutics
KYMR
$2.95B
| $12.6M | 0.85% | 259,895 +12,368 | +5% | +$600K |
|
24
Varonis Systems
VRNS
$6.61B
| $12.6M | 0.85% | 218,013 +79,338 | +57% | +$4.57M |
|
|
ONCR
25
DELISTED
Oncorus, Inc.
ONCR
| $12.3M | 0.83% | 893,548 -9,563 | -1% | -$132K |
|